Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROPIVACAINE vs ROSIGLITAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROPIVACAINE vs ROSIGLITAZONE: Safety Overview

Metric ROPIVACAINE ROSIGLITAZONE
Total FAERS Reports 2,967 45,976
Deaths Reported 150 4,661
Death Rate 5.1% 10.1%
Hospitalizations 921 23,675
Average Patient Age 50.3 yrs 60.2 yrs
% Female Patients 72.3% 42.8%
FDA Approval Date Apr 11, 2016 Jan 25, 2013
Manufacturer NorthStar Rx LLC N/A
Route EPIDURAL N/A
Marketing Status Prescription Discontinued